TY - JOUR
T1 - Specific binding of the C-terminal Src homology 2 domain of the p85α subunit of phosphoinositide 3-kinase to phosphatidylinositol 3,4,5-trisphosphate
T2 - Localization and engineering of the phosphoinositide-binding motif
AU - Ching, Tsui Ting
AU - Lin, Ho Pi
AU - Yang, Chih Cheng
AU - Oliveira, Marcos
AU - Lu, Pei Jung
AU - Chen, Ching Shih
PY - 2001/11/23
Y1 - 2001/11/23
N2 - Phosphoinositide second messengers, generated from the action of phosphoinositide 3-kinase (PI3K), mediate an array of signaling pathways through the membrane recruitment and activation of downstream effector proteins. Although pleckstrin domains of many target proteins have been shown to bind phosphatidylinositol 3,4,5-trisphosphate (PIP3) and/or phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2) with high affinity, published data concerning the phosphoinositide binding specificity of Src homology 2 (SH2) domains remain conflicting. Using three independent assays, we demonstrated that the C-terminal (CT-)SH2 domain, but not the N-terminal SH2 domain, on the PI3K p85α subunit displayed discriminative affinity for PIP3. However, the binding affinity diminished precipitously when the acyl chain of PIP3 was shortened. In addition, evidence suggests that the charge density on the phosphoinositol ring represents a key factor in determining the phosphoinositide binding specificity of the CT-SH2 domain. In light of the largely shared structural features between PIP3 and PI(4,5)P2, we hypothesized that the PIP3-binding site on the CT-SH2 domain encompassed a sequence that recognized PI(4,5)P2. Based on a consensus PI(4,5)P2-binding sequence (KXXXXXKXKK; K denotes Arg, Lys, and His), we proposed the sequence 18RNKAENLLRGKR29 as the PIP3-binding site. This binding motif was verified by using a synthetic peptide and site-directed mutagenesis. More importantly, neutral substitution of flanking Arg 18 and Arg29 resulted in a switch of ligand specificity of the CT-SH2 domain to PI(4,5)P2 and PI(3,4)P2, respectively. Together with computer modeling, these mutagenesis data suggest a pseudosymmetrical relationship in the recognition of the phosphoinositol head group at the binding motif.
AB - Phosphoinositide second messengers, generated from the action of phosphoinositide 3-kinase (PI3K), mediate an array of signaling pathways through the membrane recruitment and activation of downstream effector proteins. Although pleckstrin domains of many target proteins have been shown to bind phosphatidylinositol 3,4,5-trisphosphate (PIP3) and/or phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2) with high affinity, published data concerning the phosphoinositide binding specificity of Src homology 2 (SH2) domains remain conflicting. Using three independent assays, we demonstrated that the C-terminal (CT-)SH2 domain, but not the N-terminal SH2 domain, on the PI3K p85α subunit displayed discriminative affinity for PIP3. However, the binding affinity diminished precipitously when the acyl chain of PIP3 was shortened. In addition, evidence suggests that the charge density on the phosphoinositol ring represents a key factor in determining the phosphoinositide binding specificity of the CT-SH2 domain. In light of the largely shared structural features between PIP3 and PI(4,5)P2, we hypothesized that the PIP3-binding site on the CT-SH2 domain encompassed a sequence that recognized PI(4,5)P2. Based on a consensus PI(4,5)P2-binding sequence (KXXXXXKXKK; K denotes Arg, Lys, and His), we proposed the sequence 18RNKAENLLRGKR29 as the PIP3-binding site. This binding motif was verified by using a synthetic peptide and site-directed mutagenesis. More importantly, neutral substitution of flanking Arg 18 and Arg29 resulted in a switch of ligand specificity of the CT-SH2 domain to PI(4,5)P2 and PI(3,4)P2, respectively. Together with computer modeling, these mutagenesis data suggest a pseudosymmetrical relationship in the recognition of the phosphoinositol head group at the binding motif.
UR - http://www.scopus.com/inward/record.url?scp=0035941295&partnerID=8YFLogxK
U2 - 10.1074/jbc.M105159200
DO - 10.1074/jbc.M105159200
M3 - Article
C2 - 11555646
AN - SCOPUS:0035941295
SN - 0021-9258
VL - 276
SP - 43932
EP - 43938
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 47
ER -